View in EDS

Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II study.

Saved in:
Bibliographic Details
Title: Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II study.
Authors: Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA. nshort@mdanderson.org., Bataller A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang W; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Maiti A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA., Nguyen D; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hachem MC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA., Bi TM; Hematopoietic Biology and Malignancy Department, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA., Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA., Ohanian M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA., Loghavi S; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Karrar O; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA., Bachireddy P; Hematopoietic Biology and Malignancy Department, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hwang H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Huang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA.
Source: Journal of hematology & oncology [J Hematol Oncol] 2026 Jun 27. Date of Electronic Publication: 2026 Jun 27.
Publication Type: Journal Article
Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42365365
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Short+NJ%22">Short NJ</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA. nshort@mdanderson.org.<br /><searchLink fieldCode="AU" term="%22Bataller+A%22">Bataller A</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22DiNardo+CD%22">DiNardo CD</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Montalban-Bravo+G%22">Montalban-Bravo G</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Wang+SA%22">Wang SA</searchLink>; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Wang+W%22">Wang W</searchLink>; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Maiti+A%22">Maiti A</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+D%22">Nguyen D</searchLink>; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hachem+MC%22">Hachem MC</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Bi+TM%22">Bi TM</searchLink>; Hematopoietic Biology and Malignancy Department, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Issa+GC%22">Issa GC</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Chien+KS%22">Chien KS</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Ohanian+M%22">Ohanian M</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Kadia+TM%22">Kadia TM</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Loghavi+S%22">Loghavi S</searchLink>; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Karrar+O%22">Karrar O</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Bachireddy+P%22">Bachireddy P</searchLink>; Hematopoietic Biology and Malignancy Department, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hwang+H%22">Hwang H</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Huang+X%22">Huang X</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Garcia-Manero+G%22">Garcia-Manero G</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Ravandi+F%22">Ravandi F</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Unit 428, 1400 Holcombe Blvd, Houston, TX, 77030, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101468937%22">Journal of hematology & oncology</searchLink> [J Hematol Oncol] 2026 Jun 27. <i>Date of Electronic Publication: </i>2026 Jun 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Biomed+Central%22">Biomed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101468937 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1756-8722 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217568722%22">17568722 </searchLink><i>NLM ISO Abbreviation: </i>J Hematol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42365365
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13045-026-01825-3
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Short NJ
      – PersonEntity:
          Name:
            NameFull: Bataller A
      – PersonEntity:
          Name:
            NameFull: DiNardo CD
      – PersonEntity:
          Name:
            NameFull: Montalban-Bravo G
      – PersonEntity:
          Name:
            NameFull: Wang SA
      – PersonEntity:
          Name:
            NameFull: Wang W
      – PersonEntity:
          Name:
            NameFull: Maiti A
      – PersonEntity:
          Name:
            NameFull: Nguyen D
      – PersonEntity:
          Name:
            NameFull: Hachem MC
      – PersonEntity:
          Name:
            NameFull: Bi TM
      – PersonEntity:
          Name:
            NameFull: Issa GC
      – PersonEntity:
          Name:
            NameFull: Chien KS
      – PersonEntity:
          Name:
            NameFull: Ohanian M
      – PersonEntity:
          Name:
            NameFull: Kadia TM
      – PersonEntity:
          Name:
            NameFull: Loghavi S
      – PersonEntity:
          Name:
            NameFull: Karrar O
      – PersonEntity:
          Name:
            NameFull: Bachireddy P
      – PersonEntity:
          Name:
            NameFull: Hwang H
      – PersonEntity:
          Name:
            NameFull: Huang X
      – PersonEntity:
          Name:
            NameFull: Garcia-Manero G
      – PersonEntity:
          Name:
            NameFull: Ravandi F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 06
              Text: 2026 Jun 27
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1756-8722
          Titles:
            – TitleFull: Journal of hematology & oncology
              Type: main
ResultId 1